Business and Innovation News

Tuesday, 15 March 2022

INBRAIN Neuroelectronics signs an agreement to develop neurotechnology patented by six public research institutions

INBRAIN Neuroelectronics is a technology company developing graphene-based applications for neurological diseases founded by researchers from IMB-CNM-CSIC, ICN2 and ICREA who lead some of the research areas of the Graphene Flagship. The agreement paves the way for further development and industrialization of patented technology from CSIC, ICN2, ICREA, CIBERBBN, UAB and IDIBAPS.

Tuesday, 22 February 2022

ICN2 Business and Innovation at Transfiere in Malaga

A European Forum for Science, Technology and Innovation, “Transfiere” was held in Malaga on February 16-17.

Wednesday, 12 January 2022

Open Knowledge Programme: Intellectual Property and Innovation

Dr. Pablo Pomposiello, Leader of the Business and Innovation Department, and Jordi Reverter, Intellectual Property and Technology Transfer Officer, discussed intellectual property protection, innovation and translation of technology from research to industry in a two-day appointment of the OKP series.

Monday, 14 February 2022

ICN2 in the top 10 of Catalan research institutions for number of health spin-offs and investments in 2021

The “BioRegió” Report 2021 provides data about the new health-related companies created from Catalan universities and research institutes in the last year. The ICN2 is well positioned, with 6 start-ups and 17.4 millions of euros invested in them.

Thursday, 08 July 2021

INBRAIN Neuroelectronics collaborates with Merck to develop the next generation of bioelectronic therapies

The ICN2 and ICREA’s spin-off INBRAIN Neurolectronics starts a collaboration with the leading biotechnology company Merck. They will develop novel graphene bioelectronics devices for vagus nerve therapies, targeting severe chronic diseases.